Other News

Saghmos Therapeutics Announces Notice of Allowance for Second US Patent for Phase 3-Ready Cardiorenal Metabolic Modulator ST-62516

GREENWICH, Conn.–(BUSINESS WIRE)–Saghmos Therapeutics, Inc. (Saghmos), a privately held biopharmaceutical company, announced a Notice of Allowance for a second US patent for its Phase 3-ready product, ST-62516 (trimetazidine), a cardiorenal metabolic modulator. The patent will provide exclusivity through 2037, with broad claims for the reduction of acute kidney injury and […]

XCath CEO Eduardo Fonseca Highlights Potential for Telesurgery at Inaugural SRS Telesurgery Consensus Conference

HOUSTON–(BUSINESS WIRE)–XCath, an early-stage medical device company dedicated to expanding endovascular treatment modalities through its robotic systems and guidewires, took part in a panel last week at the first-ever Telesurgery Consensus Conference hosted by the Society of Robotic Surgery (SRS). The event, which took place in Orlando, Florida from February 3-4, provided a forum for international leaders in the surgical and robotic spaces to examine priorities and challenges in the ever-cha

Sun Life partners with Somatus to provide comprehensive services for late-stage kidney disease and cardiovascular care

WELLESLEY, Mass., Feb. 6, 2024 /PRNewswire/ — Sun Life U.S. has named Somatus as a preferred partner to further support the company’s strategy to increase access to care while managing rising costs. Through this partnership, Somatus will deliver a unique and coordinated care model for…

Study Results: MD Revolution and Cardiac Solutions Achieve 50% Reduction in 30-Day Cardiovascular Readmissions Using RevUp Remote Care Management

SAN DIEGO–(BUSINESS WIRE)–MD Revolution, the leader in remote care management solutions for health systems and multi-specialty clinics, announced today that its partner, Cardiac Solutions achieved a 50% reduction in hospital cardiovascular readmission rates by using RevUp Remote Patient Monitoring and Chronic Care Management as part of their program. “Our goal […]